Canagliflozin is a medication used to manage type 2 diabetes. It belongs to a class of drugs called SGLT2 inhibitors, which work by helping the kidneys remove excess sugar from the bloodstream through urine. This can help lower blood sugar levels and improve overall glycemic control. In addition to its primary use for diabetes, canagliflozin may also provide benefits for heart and kidney health. It has been shown to reduce the risk of cardiovascular events in patients with type 2 diabetes and existing heart disease, making it a valuable option for many individuals managing these conditions.